9 results
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
Drugs #Membrane ... #Channels #Actions ... #Antiarrhythmic ... #Pharmacology # ... Cardiology #Table
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
- Sodium Channel ... #Sodium #Channel ... #Na #cardiology ... #pharmacology # ... table #comparison
Drugs affecting the cardiac action potential. The sharp rise in voltage ("0") corresponds to the influx
Drugs affecting ... to the sodium-channel ... voltage-sensitive calcium channels ... #Cardiology #Antiarrhythmics ... #Classes #Effect
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Antiarrhythmics ... 1 - Sodium Channel ... Block fast Na+ channels ... blocking effects ... Vaughan #Williams #Pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... blocking effects ... inotropy) ACCP Cardiology ... #Pharmacology #
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
Class III Antiarrhythmics ... - Potassium Channel ... Indications and Side Effects ... #Potassium #Channel ... #cardiology
Sedative-Hypnotic Drugs
Benzodiazepines:
 - Bind to specific GABAA receptor subunits at central nervous system (CNS) neuronal synapses
Sedative-Hypnotic Drugs ... GABA-mediated chloride ion channel ... GABA-mediated chloride ion channel ... #medications #pharmacology ... #comparison #table
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
tachycardia Calcium Channel ... potential arrhythmias Class ... I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Class: Selective ... Dosing: 250 mcg tablet ... have been a few changes ... have any clinical effect